Skip to main content
FDA Shortage Check

Is Rifampin Capsule in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Rifampin Capsule: in shortage (FDA, Oct 24)

Capsules
A generic capsule, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Discontinuation of the manufacture of the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
DRUG
Rifampin Capsule
FDA LISTING
FORM
capsules
STATUS
Currently in Shortage
FIRST POSTED
Dec 22, 2021
LAST FDA UPDATE
Oct 23, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 9 presentations: 4 unavailable · 0 limited · 5 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Rifampin Capsule. 9 presentations from 2 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Epic Pharma, LLC6 presentations · 4 unavailable · 2 available or not stated

Contact (FDA's listing): (718) 276-8600 ext. 3

  • 150 mg

    Rifampin, Capsule, 150 mg (NDC 42806-801-01)

    Discontinuation of the manufacture of the drug

    NDC 42806-801-01Reverified

    Unavailable

  • 300 mg

    Rifampin, Capsule, 300 mg (NDC 42806-799-01)

    Discontinuation of the manufacture of the drug

    NDC 42806-799-01Reverified

    Unavailable

  • 300 mg

    Rifampin, Capsule, 300 mg (NDC 42806-799-05)

    Discontinuation of the manufacture of the drug

    NDC 42806-799-05Reverified

    Unavailable

  • 300 mg

    Rifampin, Capsule, 300 mg (NDC 42806-799-30)

    Discontinuation of the manufacture of the drug

    NDC 42806-799-30Reverified

    Unavailable

  • 150 mg

    Rifampin, Capsule, 150 mg (NDC 42806-801-30)

    NDC 42806-801-30Reverified

    Available

  • 300 mg

    Rifampin, Capsule, 300 mg (NDC 42806-799-60)

    NDC 42806-799-60Reverified

    Available

Lupin Pharmaceuticals, Inc.3 presentations · 3 available or not stated

Contact (FDA's listing): 866-587-4617

  • 150 mg

    Rifampin, Capsule, 150 mg (NDC 68180-658-06)

    NDC 68180-658-06Reverified

    Available

  • 300 mg

    Rifampin, Capsule, 300 mg (NDC 68180-659-06)

    NDC 68180-659-06Reverified

    Available

  • 300 mg

    Rifampin, Capsule, 300 mg (NDC 68180-659-07)

    NDC 68180-659-07Reverified

    Available

What the manufacturers told FDA

No recovery estimate posted by the makers.

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Discontinuation of the manufacture of the drug

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Shown as FDA status, not as suggestions.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Rifampin Capsule in shortage?
Yes. As of Oct 24, 2026, FDA lists Rifampin Capsule as currently in shortage: 9 presentations, 4 unavailable and 0 limited.
When will the Rifampin Capsule shortage end?
FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Rifampin Capsule?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.